DESCRIPTION (provided by applicant): Recent evidence suggests that the primary cause of Alzheimer's disease is the progressive accumulation of neurotpxic oligomeric assemblies of the Abeta 1-42 prote ...SBIR Phase I 2005 Department of Health and Human Services
DESCRIPTION (provided by applicant): The molecular and cellular details underlying Alzheimer's disease (AD) are being defined at an accelerating pace, leading to new therapeutic discovery efforts tha ...SBIR Phase I 2005 Department of Health and Human Services
Acumen Pharmaceuticals, Inc.
| Acumen Pharmaceuticals, Inc.
385 Oyster Point Blvd.
South San Francisco, CA, 94080
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|